TABLE 2

Femoral venous blood flow, arterial blood concentration, plasma substrate concentration, hormone concentration, and serum cytokine concentration in the control and intralipid trial in women and men

ControlIntralipid
Preclamp (300 min)End of clamp (420 min)Preclamp (300 min)End of clamp (420 min)
RER
    Women0.80 ± 0.020.89 ± 0.010.77 ± 0.010.79 ± 0.01
    Men0.78 ± 0.020.87 ± 0.010.76 ± 0.010.78 ± 0.01*
Blood flow (ml/min)
    Women523 ± 44607 ± 55626 ± 91564 ± 93
    Men520 ± 90670 ± 58472 ± 83491 ± 58
Arterial blood glucose (mmol/l)
    Women5.4 ± 0.15.4 ± 0.15.3 ± 0.15.3 ± 0.1
    Men5.2 ± 0.15.1 ± 0.15.3 ± 0.15.3 ± 0.1
Plasma LCFA (μmol/l)
    Women541 ± 50§9 ± 41,706 ± 1971,415 ± 236
    Men519 ± 9215 ± 62,020 ± 2161,572 ± 111
Plasma triacylglycerol (μmol/l)
    Women484 ± 24409 ± 261,706 ± 209*2,038 ± 351
    Men540 ± 45471 ± 472,478 ± 1802,765 ± 253
Plasma insulin (μU/ml)
    Women8.0 ± 0.887.7 ± 5.79.4 ± 0.788.8 ± 2.9
    Men7.8 ± 0.594.3 ± 9.510.1 ± 1.086.9 ± 7.6
Plasma epinephrine (nmol/l)
    Women0.36 ± 0.060.40 ± 0.090.21 ± 0.040.47 ± 0.11
    Men0.34 ± 0.070.45 ± 0.090.26 ± 0.050.38 ± 0.09
Plasma norepinephrine (nmol/l)
    Women1.2 ± 0.231.33 ± 0.280.98 ± 0.111.34 ± 0.17
    Men1.46 ± 0.361.48 ± 0.351.14 ± 0.181.38 ± 0.21
Serum TNF-α (pg/ml)
    Women2.21 ± 0.662.08 ± 0.662.27 ± 0.852.28 ± 0.82
    Men1.50 ± 0.321.44 ± 0.451.42 ± 0.361.49 ± 0.45
Serum adiponectin (pg/ml)
    Women26.5 ± 3.125.0 ± 2.928.5 ± 2.227.1 ± 2.6
    Men10.5 ± 1.39.9 ± 1.211.1 ± 1.310.1 ± 1.2
Lactate release (μmol/min)
    Women5 ± 274 ± 611 ± 2*111 ± 11*
    Men6 ± 263 ± 911 ± 1*95 ± 16*
  • Data are means ± SE of eight determinations in both women and men.

  • *P < 0.05,

  • P < 0.001 vs. control trial;

  • P < 0.05 vs. women,

  • §P < 0.05,

  • P < 0.001 vs. previous time point.